{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:37:23Z","timestamp":1792888643796,"version":"4.5.0"},"reference-count":26,"publisher":"American Public Health Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Public Health"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:p>Objectives. To identify drug prevalence through the analysis of drug material and paraphernalia (DMP) collected from scenes of fentanyl-involved fatal accidental drug overdoses in San Francisco, California, throughout 2022.<\/jats:p>\n                  <jats:p>Methods. We conducted gas chromatography\u2013mass spectrometry testing on 409 items of DMP (e.g., glass pipes, syringes, aluminum foil, powders) from 137 cases, and we further tested 132 DMP items using liquid chromatography\u2013tandem mass spectrometry in context with decedent information and toxicology findings.<\/jats:p>\n                  <jats:p>Results. We detected fentanyl in 106 cases (77%); 35 (33%) contained fentanyl either alone or with fentanyl precursors or breakdown products. Of the 106 fentanyl-positive cases, we codetected cocaine in 29 (27%) and methamphetamine in 16 (15%). Overall, we detected methamphetamine in 58 (42%) cases (25 in isolation), cocaine in 68 (50%) cases (18 in isolation), and fentanyl analogs in 33 (24%) cases (4 in isolation). We detected 38 novel fentanyl analogs and precursors of analogs.<\/jats:p>\n                  <jats:p>Conclusions. We observed fentanyl use in combination with stimulants (a characteristic pattern of the opioid epidemic fourth wave). Smoking fentanyl powder using aluminum foil or snorting were the most inferred. We established polysubstance use and emerging potent novel fentanyl analogs use. ( Am J Public Health. 2025;115(4):555\u2013565. https:\/\/doi.org\/10.2105\/AJPH.2024.307948 )<\/jats:p>","DOI":"10.2105\/ajph.2024.307948","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:03:17Z","timestamp":1741795397000},"page":"555-565","source":"Crossref","is-referenced-by-count":17,"title":["The Fourth Wave of the Opioid Epidemic: Increasing Combination of Fentanyl With Stimulants"],"prefix":"10.2105","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7546-5499","authenticated-orcid":false,"given":"Katie","family":"Diekhans","sequence":"first","affiliation":[{"name":"All authors are with the Office of the Chief Medical Examiner, San Francisco, CA. Luke N. Rodda is also with the Department of Laboratory Medicine, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0224-4083","authenticated-orcid":false,"given":"Jihau","family":"Yu","sequence":"additional","affiliation":[{"name":"All authors are with the Office of the Chief Medical Examiner, San Francisco, CA. Luke N. Rodda is also with the Department of Laboratory Medicine, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-112X","authenticated-orcid":false,"given":"Sue","family":"Pearring","sequence":"additional","affiliation":[{"name":"All authors are with the Office of the Chief Medical Examiner, San Francisco, CA. Luke N. Rodda is also with the Department of Laboratory Medicine, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6617-9547","authenticated-orcid":false,"given":"Robert","family":"Almeida","sequence":"additional","affiliation":[{"name":"All authors are with the Office of the Chief Medical Examiner, San Francisco, CA. Luke N. Rodda is also with the Department of Laboratory Medicine, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8660-6481","authenticated-orcid":false,"given":"Luke N.","family":"Rodda","sequence":"additional","affiliation":[{"name":"All authors are with the Office of the Chief Medical Examiner, San Francisco, CA. Luke N. Rodda is also with the Department of Laboratory Medicine, University of California, San Francisco."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"844","reference":[{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000717"},{"key":"bib3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103402"},{"key":"bib5","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkae062"},{"key":"bib6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108722"},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2021.111083"},{"key":"bib8","doi-asserted-by":"publisher","DOI":"10.1097\/PAF.0000000000000798"},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"bib10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac543"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109003"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7306a2"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkae009"},{"key":"bib14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109398"},{"key":"bib15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108416"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107779"},{"key":"bib17","author":"Centers for Disease Control and Prevention","year":"2024","journal-title":"SUDORS dashboard: fatal drug overdose data."},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108162"},{"key":"bib20","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304694"},{"key":"bib21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.08.006"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00634-4"},{"key":"bib23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0303403"},{"key":"bib24","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)00035-5"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.08.015"},{"key":"bib26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2011.05.014"},{"key":"bib27","first-page":"104417:104417","author":"Palamar JJ","year":"2024","journal-title":"Int J Drug Policy."},{"key":"bib28","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7235a3"},{"key":"bib29","first-page":"100321","volume":"11","author":"Lassi N.","year":"2023","journal-title":"Explor Res Clin Soc Pharm."}],"container-title":["American Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ajph.aphapublications.org\/doi\/pdf\/10.2105\/AJPH.2024.307948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T16:03:25Z","timestamp":1741795405000},"score":1,"resource":{"primary":{"URL":"https:\/\/ajph.aphapublications.org\/doi\/full\/10.2105\/AJPH.2024.307948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.2105\/AJPH.2024.307948"],"URL":"https:\/\/doi.org\/10.2105\/ajph.2024.307948","relation":{},"ISSN":["0090-0036","1541-0048"],"issn-type":[{"value":"0090-0036","type":"print"},{"value":"1541-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}